Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study

NCT04080544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Cognitive Decline

Interventions

DRUG: [18F]AV-1451
PROCEDURE: Positron Emission Tomography

Sponsor

Neil M Rofsky, MD, MHA